Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C025655
http://purl.bioontology.org/ontology/MESH/C025655
|
|---|---|
| Preferred Name | lofexidine |
| Synonyms |
BritLofex
2-(alpha-(2,6-dichlorophenoxy)ethyl) delta-2-imidazoline
Lucemyra
lofexidine hydrochloride
1H-imidazole, 2-(1-(2,6-dichlorophenoxy)ethyl)-4,5-dihydro-
lofexidine, (+-)-isomer
lofexidine monohydrochloride
Lofexidine mono-hydrochloride
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
BritLofex
2-(alpha-(2,6-dichlorophenoxy)ethyl) delta-2-imidazoline
Lucemyra
lofexidine hydrochloride
1H-imidazole, 2-(1-(2,6-dichlorophenoxy)ethyl)-4,5-dihydro-
lofexidine, (+-)-isomer
lofexidine monohydrochloride
Lofexidine mono-hydrochloride
See more
See less
|
|---|---|
| prefLabel | lofexidine
|
| Scope Statement | reduces narcotic withdrawal symptoms; RN given refers to parent cpd without isomeric designation; structure in Negwer, 5th ed, #6247
|
| type | |
| isa | |
| PA |
D009292
D000959
D058647
|
| tui |
T109
T121
|
| Has mapping qualifier | |
| HM | D003000/Q000031
|
| SC | 1
|
| TERMUI |
T346518
T534967
T115281
T346519
T000993801
T115280
T766580
T678320
See more
See less
|
| TH |
UK
NLM (2020)
FDA SRS (2013)
USAN (1986)
USAN (19XX)
INN (19XX)
NLM (2006)
NLM (1980)
NLM (2011)
See more
See less
|
| SRC | Pharmacol Biochem Behav 1980;12(4):573
|
| MMR | 20191030
|
| notation | C025655
|
| Semantic type UMLS property | |
| RR |
31036-80-3 (lofexidine)
21498-08-8 (lofexidine hydrochloride)
V47G1SDI1B
73372-53-9
|
| cui |
C0065152
C4694573
C0953927
C0591196
C0771049
|
| MeSH Frequency | 143
|
| LT | TRD
|
| DSC | 19800812
|
| Inverse of RB |
UI82K0T627
V47G1SDI1B
73372-53-9
0
|
| Mapped to | |
| MDA | 19800812
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |